Why Are Healthcare Providers Investing in Point-of-Care Molecular Diagnostics Technologies?
The global market for point-of-care molecular diagnostics is expected to reach USD 7.09 billion by 2030, from USD 4.30 billion in 2025, with a CAGR of 10.5%. Growth is mainly driven by the increasing prevalence of infectious diseases and cancer, which boosts demand for rapid and accurate testing solutions. Additionally, there is a growing focus on decentralized diagnostics to facilitate quick...
0 Commenti 0 condivisioni 101 Views 0 Anteprima
Sponsorizzato